comparemela.com

Heena Dhedhi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lupin : May 16, 2024 Lupin Receives Approval from U S FDA for Midostaurin Capsules

Mumbai, Naples, May 16, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its Abbreviated.

South africaUnited statesAsia pacificHeena dhedhiCorporate communicationsNovartis pharmaceuticals corporationBiotechnology pharmaceuticalsLupin limitedDrug administrationUnited states foodAbbreviated new drug applicationMidostaurin capsulesNovartis pharmaceuticalsLatin americaMiddle eastGreat place

Lupin : May 6, 2024 Lupin Receives Approval from U S FDA for Travoprost Ophthalmic Solution USP

Mumbai, Naples, May 06, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its Abbreviated.

United statesSouth africaHeena dhedhiAsia pacificLupin limitedBiotechnology pharmaceuticalsSandoz incDrug administrationCorporate communicationsUnited states foodAbbreviated new drug applicationTravoprost ophthalmic solutionIonic buffered solutionOphthalmic solutionLatin americaMiddle east

Lupin : May 3, 2024 Lupin Launches Rymti® Biosimilar Etanercept in Canada

Rymti® is Lupin s first biosimilar launch in Canada Rymti® is approved for all indications of the reference product Enbrel® .

South africaHeena dhedhiVinita guptaMichel robidouxAsia pacificCyrus karkariaCorporate communicationsBiotechnology pharmaceuticalsLupin limitedHealth canadaSandoz canadaChief executive officerPresident biotechnologyGeneral managerTumor necrosis factorLatin america

Lupin : April 25, 2024 Lupin Receives Approval from U S FDA for Loteprednol Etabonate Ophthalmic Suspension, 0 5%

Mumbai, Naples, April 25, 2024: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration for its.

United statesSouth africaHeena dhedhiAsia pacificBausch lomb incLupin limitedCorporate communicationsDrug administrationBiotechnology pharmaceuticalsUnited states foodAbbreviated new drug applicationLoteprednol etabonate ophthalmic suspensionOphthalmic suspensionEtabonate ophthalmic suspensionLatin americaMiddle east

Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States

Mumbai, Naples, April 20, 2024: Global pharma major Lupin Limited today announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after having received.

South africaUnited statesAsia pacificHeena dhedhiBiotechnology pharmaceuticalsLupin limitedAstellas pharma global development incCorporate communicationsAstellas pharma incDrug administrationMirabegron extended release tabletsUnited states foodExtended release tabletsAstellas pharma global developmentLatin americaMiddle east

vimarsana © 2020. All Rights Reserved.